<i>In Silico</i> Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-&#954;B Ligand (RANKL).

Melagraki, Georgia; Ntougkos, Evangelos; Papadopoulou, Dimitra; Rinotas, Vagelis; Leonis, Georgios; Douni, Eleni; Afantitis, Antreas; Kollias, George

In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).

Melagraki, Georgia; Ntougkos, Evangelos; Papadopoulou, Dimitra; Rinotas, Vagelis; Leonis, Georgios; Douni, Eleni; Afantitis, Antreas; Kollias, George.

Afiliação

Melagraki G; Hellenic Military Academy, Vari, Greece.
Ntougkos E; Division of Immunology Biomedical Sciences Research Center "Alexander Fleming,", Vari, Greece.
Papadopoulou D; Division of Immunology Biomedical Sciences Research Center "Alexander Fleming,", Vari, Greece.
Rinotas V; Department of Experimental Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Leonis G; Division of Immunology Biomedical Sciences Research Center "Alexander Fleming,", Vari, Greece.
Douni E; Department of Biotechnology, Agricultural University of Athens, Athens, Greece.
Afantitis A; NovaMechanics Ltd., Nicosia, Cyprus.
Kollias G; Division of Immunology Biomedical Sciences Research Center "Alexander Fleming,", Vari, Greece.

Front Pharmacol ; 9: 800, 2018.

Article em En | MEDLINE | ID: mdl-30090063

Palavras-chave

RANKL inhibitors; autoimmune diseases; direct TNF inhibitors; molecular dynamics; natural products; virtual screening

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article